International Journal of Alzheimer’s Disease

Mild Cognitive Impairment: Beyond Memory Dysfunction


Publishing date
01 May 2012
Status
Published
Submission deadline
01 Nov 2011

Lead Editor

1Section of Geriatric Medicine, Cardiff University, Cardiff CF64 2XX, UK

2Geriatric Department, Slovak Medical University, Krajinska 91, 82 56 Bratislava, Slovakia

3Institute of Clinical Neurobiology, 18 Kenyongasse, Vienna 1070, Austria


Mild Cognitive Impairment: Beyond Memory Dysfunction

Description

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts to characterize mild cognitive impairment (MCI). Greater understanding of this syndrome is most likely to be achieved by a multidisciplinary research approach. This requires investigation of the integrity of brain functions additional to those typically investigated clinically, particularly if functional integrity is found to be heterogeneous with respect to aetiology. Potential topics include, but are not limited to:

  • Aetiology of MCI: new concepts
  • Evidence for new aspects of brain dysfunction in MCI
  • Biomarkers and genetics in MCI: new developments/concepts
  • Latest technologies for the evaluation of MCI
  • Methodological and ethical issues in MCI research
  • Translating MCI research into clinical practice
  • Pharmacological approaches to symptom management and disease modification in MCI
  • Improvements in care and support for patients with MCI and their families
  • Operationalizing MCI criteria for research and clinical use

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/ijad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2012
  • - Article ID 262305
  • - Editorial

Mild Cognitive Impairment: Beyond Memory Dysfunction

Andrea Tales | Antony Bayer | ... | Kurt A. Jellinger
  • Special Issue
  • - Volume 2012
  • - Article ID 936272
  • - Review Article

Executive Dysfunction in MCI: Subtype or Early Symptom

Ivar Reinvang | Ramune Grambaite | Thomas Espeseth
  • Special Issue
  • - Volume 2012
  • - Article ID 421452
  • - Review Article

Promising Genetic Biomarkers of Preclinical Alzheimer's Disease: The Influence of APOE and TOMM40 on Brain Integrity

Beata Ferencz | Sari Karlsson | Grégoria Kalpouzos
  • Special Issue
  • - Volume 2012
  • - Article ID 608013
  • - Clinical Study

Risk and Determinants of Dementia in Patients with Mild Cognitive Impairment and Brain Subcortical Vascular Changes: A Study of Clinical, Neuroimaging, and Biological Markers—The VMCI-Tuscany Study: Rationale, Design, and Methodology

Anna Poggesi | Emilia Salvadori | ... | Domenico Inzitari
  • Special Issue
  • - Volume 2012
  • - Article ID 291920
  • - Clinical Study

Mild Cognitive Impairment: Statistical Models of Transition Using Longitudinal Clinical Data

Erin L. Abner | Richard J. Kryscio | ... | Frederick A. Schmitt
  • Special Issue
  • - Volume 2012
  • - Article ID 725329
  • - Clinical Study

Memory Complaints Associated with Seeking Clinical Care

Carolina Pires | Dina Silva | ... | Alexandre de Mendonça
  • Special Issue
  • - Volume 2012
  • - Article ID 209570
  • - Clinical Study

Effects of Anosognosia on Perceived Stress and Cortisol Levels in Alzheimer’s Disease

Genevieve Arsenault-Lapierre | Victor Whitehead | ... | Howard Chertkow
  • Special Issue
  • - Volume 2012
  • - Article ID 253153
  • - Review Article

Specific EEG Changes Associated with Atrophy of Hippocampus in Subjects with Mild Cognitive Impairment and Alzheimer's Disease

D. V. Moretti | A. Prestia | ... | G. B. Frisoni
  • Special Issue
  • - Volume 2012
  • - Article ID 483469
  • - Clinical Study

A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer’s Disease

D. P. Devanand | Xinhua Liu | ... | Gregory H. Pelton
International Journal of Alzheimer’s Disease
 Journal metrics
Acceptance rate17%
Submission to final decision100 days
Acceptance to publication36 days
CiteScore3.800
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.